Granules India is planning to focus on Research and Development (R&D) and formulations. Moreover, the company may look at acquiring companies having high technology in formulations manufacturing or with a sizable formulations portfolio. The company would like to make 1-2 acquisitions preferably in the US and in India if it could find a right company.
Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.
